Smac peptide and doxorubicin-encapsulated nanoparticles: design, preparation, computational molecular approach and in vitro studies on cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Smac peptide and doxorubicin-encapsulated nanoparticles: design, preparation, computational molecular approach and in vitro studies on cancer cells
Authors
Keywords
-
Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2020-09-11
DOI
10.1080/07391102.2020.1819420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study
- (2020) Mojgan Nejabat et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview
- (2019) Iulia Ioana Lungu et al. MOLECULES
- DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway
- (2019) Danqi Chang et al. Frontiers in Pharmacology
- Applications of nanoparticle systems in drug delivery technology
- (2018) Syed A.A. Rizvi et al. SAUDI PHARMACEUTICAL JOURNAL
- Pharmacokinetic study of solid-lipid-nanoparticles of altretamine complexed epichlorohydrin-β-cyclodextrin for enhanced solubility and oral bioavailability
- (2017) Bina Gidwani et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Double emulsion solvent evaporation techniques used for drug encapsulation
- (2015) Muhammad Iqbal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing
- (2014) Kiran Kumar Chereddy et al. JOURNAL OF CONTROLLED RELEASE
- PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches
- (2014) Soliman Mohammadi-Samani et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Small-molecule SMAC mimetics as new cancer therapeutics
- (2014) Longchuan Bai et al. PHARMACOLOGY & THERAPEUTICS
- AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer
- (2012) Melissa K. Brunckhorst et al. CANCER BIOLOGY & THERAPY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Binding free energy calculations and biological testing of novel thiobarbiturates as inhibitors of the human NAD+dependent histone deacetylase Sirt2
- (2011) Urszula Uciechowska et al. MedChemComm
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis
- (2010) Federica Servida et al. INVESTIGATIONAL NEW DRUGS
- Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics
- (2008) Haiying Sun et al. ACCOUNTS OF CHEMICAL RESEARCH
- The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9
- (2008) Raviraj Kulathila et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started